FOCUS-AFMNCT07314853
Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial
At risk: Primary completion moved at least 9 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Feb 2027 to Dec 2027 Show 4 more changesShow less
- Start date: Feb 2026 to Dec 2026
- Eligibility criteria expanded, about 13 words
- Study completion pushed from Feb 2029 to Dec 2029
- Site details revised
- Notable Eligibility criteria expanded, about 6 wordsv2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Arms and interventions
Participants receive intraoperative intravenous fluid therapy managed according to usual clinical practice, without artificial intelligence guidance. Fluid administration is determined by the attending clinician based on standard monitoring and clinical judgment.
Participants assigned to this arm receive intraoperative intravenous fluid therapy supported by an artificial intelligence-based clinical decision support system. The system analyzes real-time hemodynamic data and provides recommendations for fluid administration. Clinicians are strongly encouraged to follow these recommendations but may accept or override them based on clinical judgment.
Other: Artificial Intelligence-Assisted Fluid Management, Standard fluid management
Sites
1 site in 1 country
- IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale"Naples, Italy